TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ARVN

Arvinas Inc

Healthcare · Biotechnology

7.50$ -1.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Arvinas Inc (ARVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 675 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARVN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,058 1,305 1,213 1,280 1,167 1,091 1,001 909 844 718 648 675
1,033 1,280 1,190 1,257 1,150 1,067 980 890 826 701 631 652
114 312 88 155 85 101 81 115 102 143 87 94
999 1,261 1,169 1,229 1,122 1,039 954 861 788 685 615 568
21 7.2 7.1 10 15 14 8.4 11 27 6.4 6.4 54
5.5 – – – – – – – – – – –
601 645 603 680 581 530 341 300 280 284 261 113
317 257 241 347 276 230 214 158 145 143 116 83
2.1 1.9 1.5 1.2 0.8 1.8 1.9 1.8 1.9 1.7 1.8 2.1
34 18 18 23 18 13 26 17 18 24 31 7.5
0.8 0.8 0.7 0.7 0.6 0.6 0.5 0.5 0.4 0.4 0.3 0.3
457 660 610 600 586 562 660 609 564 434 387 562
-1,178 -1,333 -1,402 -1,437 -1,487 -1,532 -1,449 -1,510 -1,545 -1,612 -1,670 -1,501
54 61 72 72 72 72 73 73 73 65 64 66

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?